Trade ZYME stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Zymeworks Inc. (ZYME) is trading at US$25.03, down 2.80% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$2.05B. Over the past 52 weeks, ZYME has traded between US$16.00 and US$31.34. On Syfe you can trade ZYME with $0 commission and add it to your watchlist.
| Previous close | US$25.75 |
|---|---|
| Market cap | US$2.05B |
| P/E ratio | 24.32 |
| 52-week range | US$16.00 – US$31.34 |
| Volume | 631.86K |
| Exchange | US |
Zymeworks Inc.
Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.
Year: 2017
--B. Riley Adjusts Zymeworks Price Target to $44 From $40, Maintains Buy Rating
Aug 10, 12:29 PM · MT Newswires
Zymeworks Inc. (ZYME) stock is trading at US$25.03, -2.80% from the previous close of US$25.75.
The market cap for Zymeworks Inc. (ZYME) stock is approximately US$2.05B.
The price-to-earnings ratio for Zymeworks Inc. (ZYME) is 24.32, based on the latest reported earnings.
The 52-week high for Zymeworks Inc. (ZYME) stock is US$31.34.
The 52-week low for Zymeworks Inc. (ZYME) stock is US$16.00.
Zymeworks Inc. (ZYME) does not currently pay a dividend.
Stay on top of ZYME
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
